Recent News

• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.02.2025 - Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.02.2025 - Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.07.2025 - Second Quarter 2025 Financial Results Conference Call
• 08.07.2025 - Second Quarter 2025 Financial Results Conference Call
• 08.07.2025 - Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.07.2025 - Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
• 07.31.2025 - Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025
• 07.31.2025 - Atea Pharmaceuticals to Host Second Quarter 2025 Financial Results and Business Update Conference Call on August 7, 2025

Recent Filings

• 08.07.2025 - EX-99.1 EX-99.1
• 08.07.2025 - 8-K Current report
• 08.07.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.24.2025 - 3 Initial statement of beneficial ownership of securities
• 06.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.24.2025 - 4 Statement of changes in beneficial ownership of securities